Acute Myeloid Leukemia Statistics

Acute myeloid leukemia statistics indicate that from 1998-2002, the average age at which a person is diagnosed with the disease is 68 and the average age at death is 71. Other acute myeloid leukemia statistics show that, based on rates from 2000-2002, 1 in 250 men and women born today will be diagnosed with acute myeloid leukemia at some point in their life.

Acute Myeloid Leukemia Statistics: An Overview

The American Cancer Society estimated that 11,960 people (6,530 men and 5,430 women) would be diagnosed with acute myeloid leukemia (AML) in 2005. Acute myeloid leukemia is also known as acute myelogenous leukemia.
 

Acute Myeloid Leukemia Statistics Regarding Incidence

From 1998-2002, the median age at diagnosis for acute myeloid leukemia was 68 years of age. The percentages of people diagnosed with AML based on age were as follows:
 
  • 6.3 percent were diagnosed under age 20
  • 7.2 percent between 20 and 34
  • 7.0 percent between 35 and 44
  • 10.0 percent between 45 and 54
  • 13.9 percent between 55 and 64
  • 22.4 percent between 65 and 74
  • 24.6 percent between 75 and 84
  • 8.7 percent 85+ years of age.
 
The age-adjusted acute myeloid leukemia incidence rate was 3.8 per 100,000 men and women per year.
  

Acute Myeloid Leukemia Statistics Regarding Death Rates

From 1998-2002, the median age at death from acute myeloid leukemia was 71 years of age. The percentages of people who died from AML based on age are as follows:
 
  • 2.9 percent died under age 20
  • 3.7 percent between 20 and 34
  • 4.8 percent between 35 and 44
  • 8.4 percent between 45 and 54
  • 13.9 percent between 55 and 64
  • 26.1 percent between 65 and 74
  • 29.8 percent between 75 and 84
  • 10.3 percent 85+ years of age.
 
The age-adjusted acute myeloid leukemia death rate was 2.6 per 100,000 men and women per year in the United States.
  
(Acute Myeloid Leukemia Statistics Continued: Page 2)
Written by/reviewed by: Arthur Schoenstadt, MD
Last reviewed by: Arthur Schoenstadt, MD
Other Articles in This eMedTV Presentation